Impax Announces Interim Results, £10m Share Buyback and SKY Harbor Acquisition Amid AUM Challenges

Impax Interim Results: Navigating Choppy Waters with Strategic Flair

When a specialist asset manager like Impax announces a £10m share buyback alongside a major acquisition, you know there’s more to the story than meets the eye. Let’s unpack these interim results – a tale of shrinking AUM, strategic chess moves, and a boardroom betting big on redemption.

The Elephant in the Room: AUM Contraction

Let’s address the 800-pound gorilla first: assets under management (AUM) fell 32% to £25.3bn from September’s £37.2bn. The key drivers?

• £10.2bn net outflows (including the loss of two St. James’s Place mandates)
• £1.65bn negative market movements
• BNP Paribas AM still accounts for 35% of AUM – a concentration risk worth watching

CEO Ian Simm doesn’t sugarcoat it: “This was a notably volatile six months.” But here’s the kicker – 71% of strategies outperformed benchmarks since January 2025. The ship might be smaller, but it’s sailing more efficiently.

Strategic Plays: Buybacks & Acquisitions

Impax isn’t sitting idle. Two bold moves stand out:

1. The £10m Share Buyback

• Represents 1.5% of market cap at current prices
• Signals confidence despite 26.8% adjusted operating margin (down from 30%)
• Complements maintained dividend policy (55% payout ratio)

2. SKY Harbor Acquisition

This post-period closure adds:

• £1.1bn AUM in European short-duration high yield
• Expands fixed income capabilities (now £2.5bn AUM)
• Follows 2024’s Absalon Corporate Credit purchase

As Simm notes: “We’re building critical mass in credit – essential diversification from our equities DNA.”

Financial Health Check

The numbers reveal both pressure points and resilience:

Metric	H1 2025	H1 2024	Change
Revenue	£76.5m	£86.2m	-11.3%
Adj. Operating Profit	£20.5m	£25.8m	-20.5%
Cash Reserves	£60.3m	£60.8m	Stable

The cost-cutting bite? A 10% headcount reduction saving £11m annually. But crucially, R&D spend (new funds like Global Emerging Markets Opportunities) appears protected.

The Road Ahead: Green Shoots or False Dawn?

Three factors could swing H2 performance:

1. Market Rotation: The shift from mega-cap tech plays (which hurt Impax) to broader markets favours their style
2. Fixed Income Buildout: Credit now 5.6% of AUM vs 4% in 2024
3. Political Landscape: US tariff policies remain a wild card for sustainable transition stocks

Simm’s closing message says it all: “Our investment thesis remains compelling – the sustainable transition isn’t an ‘ESG fad’, it’s structural economic change.” The question for investors: Is Impax’s current valuation (£2.15 EBT purchase price) pricing in this conviction?

Final Thought: Contrarian Opportunity?

With PE ratio compressed and 71% strategies outperforming YTD, Impax resembles a coiled spring. The buyback suggests management agrees. As the saying goes – be fearful when others are greedy, but in this case, maybe it’s time to check where the smart money’s putting its own capital.